← Back to patent-cliff list
CAS 1002131-11-4
(S)-2-(3-(3-benzylureido)propanamido)-3-(4-(tert-butoxy)phenyl)-N-(2,2-diethoxyethyl)-N-(naphthalen-1-ylmethyl)propanamide
Codes: OP-724-010
Application context (from source-drug indications)
Hepatitis CFoscenvivintLiver cirrhosisFoscenvivintHepatitis BFoscenvivintBiliary cirrhosisFoscenvivintColorectal cancerFoscenvivintSolid tumourFoscenvivint
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Foscenvivint | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,2-diethoxyethan-1-amine→1-naphthaldehyde→2,2-diethoxy-N-(naphthalen-1-ylmethyl)ethan-1-amine→(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid→(9H-fluoren-9-yl)methyl (S)-(3-(4-(tert-butoxy)phenyl)-1-((2,2-diethoxyethyl)(naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)carbamate→(S)-2-amino-3-(4-(tert-butoxy)phenyl)-N-(2,2-diethoxyethyl)-N-(naphthalen-1-ylmethyl)propanamide→3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid→(9H-fluoren-9-yl)methyl (S)-(3-((3-(4-(tert-butoxy)phenyl)-1-((2,2-diethoxyethyl)(naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)amino)-3-oxopropyl)carbamate→(S)-2-(3-aminopropanamido)-3-(4-(tert-butoxy)phenyl)-N-(2,2-diethoxyethyl)-N-(naphthalen-1-ylmethyl)propanamide→(S)-2-(3-(3-benzylureido)propanamido)-3-(4-(tert-butoxy)phenyl)-N-(2,2-diethoxyethyl)-N-(naphthalen-1-ylmethyl)propanamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.